Andreas M Papas, Antares Health Products, United States
Vitamin E TPGS (d-α-tocopheryl polyethylene glycol 1000 succinate) combines the functions of solubilizer, emulsifier, and absorption enhancer of lipophilic and poorly soluble drugs. In addition, it enhances drug bioavailability and efficacy through inhibition of the P-glyco [....] » Read More
Title : Personalized and precision medicine (PPM) as a unique healthcare model to be set up via biodesign, bio- and chemical engineering, translational applications, and upgraded business modeling to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Traditionally a disease has been defined by its clinical presentation and observable characteristics, not by the underlying molecular mechanisms, pathways and systems biology-related processes specific to a particular patient (ignoring persons-at-risk). A new systems approach to [....] » Read More
Title : Pharmacokinetic properties of TNX-102 SL, a sublingual formulation of cyclobenzaprine hydrochloride
Bruce Daugherty, Tonix Pharmaceuticals, United States
TNX-102 SL is a sublingual formulation for cyclobenzaprine (CBP) hydrochloride (HCl) designed for bedtime dosing that is being developed for fibromyalgia (FM) via improvement in sleep quality. TNX-102 SL is a eutectic formulation of CBP and D-mannitol (see companion abstracts, Fo [....] » Read More
Title : Mannitol as eutectic forming agent for improved sublingual delivery of Cyclobenzaprine HCl
Marino Nebuloni, University of Insubria, Italy
In solid drug product formulation, the knowledge of possible interactions between the drug substance and the excipients is a crucial point for the prediction of chemical and physical stability. Often, an excipient(s) can modify the biological activity and chemical stability of th [....] » Read More
Title : Clinical decision making in advanced and metastatic breast cancer cases between PARP inhibitors and CDK4/6 inhibitors
Priya Hays, Hays Documentation Specialists, LLC, United States
Background: PARP inhibitors and CDK 4/6 inhibitors have been studied extensively as model targeted agents for advanced and metastatic breast cancer with hormone receptor positive/HER2 negative molecular subtype, the most common in the patient population. Both agents have been eva [....] » Read More
Title : Gastrointestinal performance simulation system for the analysis of eltrombopag formulations
Stella Kafkala, Genepharm Pharmaceutical Company, Greece
Eltrombopag olamine is the active substance of the innovator product Revolade, which is indicated for the treatment of chronic immune (idiopathic) thrombocytopenic purpura (ITP) and acquired severe aplastic anemia (SAA). The molecule of eltrombopag acquires 6 protonatable site [....] » Read More
Title : Microemulsion based in situ gel of Erythromycin for Ocular Ailments
Dasharath Muljibhai Patel, Gujarat Technological University, India
Background: Conventional preparation of erythromycin ointment is available in the market as an ocular formulation. Ointment dosage form is linked to many side effects, including transient blurred vision, irritation and redness of the eye. Ointment dosage form also shows very low [....] » Read More
Title : Preparation and characterization of inhaled luteolin nano-liposomes for the potential management of pulmonary arterial hypertension
Fatma Haddad, University of Bradford, United Kingdom
Luteolin is a natural flavonoid abundant in several fruits, vegetables, and medicinal herbs. Although luteolin has numerous pharmacological activities, its low water solubility and bioavailability restrict its therapeutic efficacy. This work aims to overcome these limitations by [....] » Read More
Title : Supercritical microfluidic system for production of nanoparticles and liposomes for pharmaceutical formulation
Yusuke Shimoyama, Tokyo Institute of Technology, Japan
Pharmaceutical formulation techniques have been developed as achieving controlled-release system and high bioavailability of active pharmaceutical ingredients (APIs). Formation of the pharmaceutical suspension with nanoparticles or liposomes is one of the dosage forms to increase [....] » Read More
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
A new systems approach to subclinical, predictive and/or diseased states and wellness resulted in a new Hi Tech trend in the healthcare services, namely, personalized and precision medicine (PPM). Meanwhile, despite breakthroughs in designed-driven research that have led to an i [....] » Read More
Title : Development and evaluation of prolonged-release dutasteride transdermal delivery system
Shereen M Assaf, Jordan University of Science and Technology, Jordan
Benign prostatic hyperplasia (BPH), an enlargement of the prostate affecting older men, leads to urinary complications. Oral administration of Dutasteride (DTS) is a common treatment, but it poses challenges for the elderly, including difficulty in taking the medication by mouth, [....] » Read More
Title : Potential bruton tyrosine kinase (BTK) inhibitors determined by virtual screening, molecular docking, and molecular dynamics simulation studies
Alper Onder, Canakkale Onsekiz Mart University, Turkey
Bruton tyrosine kinase (BTK) is a downstream mediator of the B cell receptor (BCR) signalling pathway and affects B cell proliferation and differentiation. Evidence showing BTK expression in the majority of hematological cells has led to the hypothesis that BTK inhibitors such as [....] » Read More
Title : In silico, synthesis, and in vitro studies of novel FOXM1 Inhibitors for targeted triple negative breast cancer therapy
Ferah Comert Onder, Canakkale Onsekiz Mart University, Turkey
Triple-negative breast cancer (TNBC) is subtype of breast cancer is known for aggressive, leading to early relapses, metastasis and poor clinical prognosis. Significant heterogeneity and drug resistant phenotype and lack of effective targeted therapeutics contribute to poor patie [....] » Read More
Title : Design and assessment of transdermal delivery system containing Levodopa-Loaded Nanoparticles
Shereen M Assaf, Jordan University of Science and Technology, Jordan
Levodopa, an essential precursor of dopamine, was widely used to address motor disorders in the early stages of Parkinson's disease. However, its effectiveness was hindered by a short plasma half-life, enzymatic conversion in the systemic circulation, limited absorption in th [....] » Read More